Scott Dennis
Physician Assistant · Bolivar, MONPI 1073916573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,283, 5.6 times the $231 reported in 2021. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$625
- Lilly USA, LLC$599
- AbbVie$416
- AstraZeneca$317
- GSK$250
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$186
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $625 |
| Lilly USA, LLC | 40 | $599 |
| AbbVie | 22 | $416 |
| AstraZeneca | 21 | $317 |
| GSK | 16 | $250 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $186 |
| Eisai Inc. | 8 | $168 |
| Abbott | 9 | $155 |
| Pfizer | 7 | $116 |
| Novartis | 5 | $95 |
| Amgen | 4 | $67 |
| Merck | 4 | $57 |
| Dexcom, Inc. | 3 | $56 |
| Radius Health, Inc. | 2 | $53 |
| Alkermes, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Lundbeck LLC | 1 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Globus Medical | 1 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Exact Sciences | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Bayer | 2 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Organon | 2 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Pulmonx Corporation | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Mylan Specialty L.p. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,736 in reported general payments places this provider in the 90th percentile of 1,380 physician assistant providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 45 | $59,876 |
| FarxigaDapagliflozin Propanediol | 45 | $36,937 |
| OzempicSemaglutide | 26 | $25,239 |
| EliquisApixaban | 21 | $20,536 |
| TrulicityDulaglutide | 15 | $14,985 |
| JardianceEmpagliflozin | 12 | $7,212 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,763 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 78 | $2,190 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $1,598 |
| Doxycycline Monohydrate | 78 | $1,306 |
| Levothyroxine Sodium | 63 | $1,057 |
| Omeprazole | 82 | $1,031 |
| Gabapentin | 107 | $996 |
| Cephalexin | 57 | $810 |
| Atorvastatin Calcium | 122 | $756 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $599 | $74,86160 claims |
| AstraZenecaFarxiga | $317 | $36,93745 claims |
| Novo NordiskOzempic | $625 | $25,23926 claims |
| PfizerEliquis | $116 | $20,53621 claims |
| Boehringer IngelheimJardiance | $18 | $7,21212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,380 physician assistant providers in Missouri.
Other physician assistant in Bolivar
- Caressa PatelBolivar$7K
- Jennifer DavissonKansas City$343K
- Andrew BergLees Summit$245K
- Sileen DowisKansas City$117K
- Daniel BeckSikeston$114K
- Amee RozancO Fallon$101K
- Autumn WillsCape Girardeau$37K
- Kimberly BrownSaint Louis$28K
- Marc ReitznerSpringfield$24K
- Justin AllphinOzark$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.